SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007045
Filing Date
2019-05-14
Accepted
2019-05-14 15:01:30
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 300740
2 ex31-1.htm EX-31.1 11670
3 ex31-2.htm EX-31.2 11709
4 ex32-1.htm EX-32.1 6168
5 ex32-2.htm EX-32.2 6261
  Complete submission text file 0001493152-19-007045.txt   2144922

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE capd-20190331.xml EX-101.INS 303767
7 XBRL SCHEMA FILE capd-20190331.xsd EX-101.SCH 25878
8 XBRL CALCULATION FILE capd-20190331_cal.xml EX-101.CAL 31575
9 XBRL DEFINITION FILE capd-20190331_def.xml EX-101.DEF 99409
10 XBRL LABEL FILE capd-20190331_lab.xml EX-101.LAB 179057
11 XBRL PRESENTATION FILE capd-20190331_pre.xml EX-101.PRE 149362
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

IRS No.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26027 | Film No.: 19822285
SIC: 2834 Pharmaceutical Preparations